Pfizer RSV vaccine protects for more than 2 seasons in older adults: Research ...Middle East

Pfizer announced Thursday that its vaccine for RSV, or respiratory syncytial virus, protects older adults for more than two seasons, according to a late-stage clinical trial. Pfizer announced that its Abrysvo vaccine “maintained consistently high protective efficacy” throughout two seasons in older adults after receiving one dose. One dose of Abrysvo was 77.8 percent effective against lower respiratory tract disease associated with RSV following the second season, according to Pfizer. This was slightly lower than the efficacy observed at the end of the first season, when one shot of the vaccine was found to be 89.9 percent effective. “We are encouraged by the level of protection

Hence then, the article about pfizer rsv vaccine protects for more than 2 seasons in older adults research was published today ( Thursday 29/02/2024 - 09:40 PM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer RSV vaccine protects for more than 2 seasons in older adults: Research )

Also on site :

• Ukraine-Russia war latest: Zelensky awaits Putin response to new peace plan while Christmas Eve blast kills 3 in Moscow
• China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
• The shadow Russia casts over Europe has forced it to face the truth: the risk of war is once again real